During the past decade, Kagoshima University Medical and Dental Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kagoshima University Medical and Dental Hospital" #1 sponsor was "Haruhiko Fukuda" with 4 trials, followed by "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Arcagy Research" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kagoshima University Medical and Dental Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Kagoshima University Medical and Dental Hospital" are "Gastric Neoplasm" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Adult T-Cell Leukemia-Lymphoma" (1 trials), "Conscious Sedation" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "Kagoshima University Medical and Dental Hospital" in a lesser frequency.

Most popular intervention types in "Kagoshima University Medical and Dental Hospital" are "Drug" (10 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Clofarabine" (1 trials), "DA-9501" (1 trials), "Dexmedetomidine" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials) and "HBI-8000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kagoshima University Medical and Dental Hospital" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kagoshima University Medical and Dental Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kagoshima University Medical and Dental Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kagoshima University Medical and Dental Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".